Alira Health strengthens its growth strategy with funding of $ 35 million, led by Creadev


[ad_1]

FRAMINGHAM, Mass .– (BUSINESS WIRE) – Alira Health (www.alirahealth.com), a leading international consultancy dedicated to advancing healthcare and life sciences, announced that it has closed a $ 35 million equity financing led by Creadev, a company of evergreen investment supported by the Mulliez family. This new partnership will help accelerate the company’s growth strategy, focused on merging the development of pharmaceutical, medical and digital technologies with healthcare through a patient-centered approach.

“I want to thank our team of investors for joining our mission to enable healthcare transformation. Their investment allows us to change the way life science consulting services are delivered, ”said Gabriele Brambilla, CEO and co-founder of Alira Health. “We are building a powerful continuum of services that spans the product and solution development lifecycle, supported by recent additions of our patient engagement, real-world evidence and advanced analytical practices. This funding allows us to advance healthcare science and strategy with our clients, improving patient outcomes.

“We were looking for investors who recognize the value of our mission, bring new perspectives to our approach, and partner with us for an ambitious, long-term plan for innovative and global growth. We are honored that Creadev, along with two other life sciences industry families, has chosen to join Alira Health and support our leadership and vision, ”said Benjamin Chambon, Chief Commercial Officer and Co-Founder of Alira Health.

“The Creadev team is proud to partner with Alira Health,” said Yohann Gbahoué, Executive Director of Creadev. “Alira Health’s approach to healthcare consulting is pioneering and we see that the impact of their work on patient outcomes grows as the company continues to execute on its strategic vision. We join the entire investment team in congratulating Gabriele and the company and look forward to supporting their future growth.

The group of new investors will hold a minority stake in Alira Health. This support allows the company to accelerate the development of its technology services and to stimulate the strategy of inorganic growth of the company in the United States and in the EU.

Creadev advisers: Finance & Taxation (Alvarez & Marsal), Legal (King & Spalding), IT / Data (Z Consulting), HR (Selescope)

Alira Health Advisors: Equiteq represented Alira Health in the transaction

About Creadev:

Creadev is a scalable, globally operating investment firm controlled by the Mulliez family, founders of one of the world’s largest Business to Consumer retail platforms. Creadev is committed to a long-term collaboration with innovative, passionate and human-driven entrepreneurs who focus on creating widespread access to essential goods and services such as healthcare, sustainable consumption and l ‘food. Based in Paris and with offices in New York, Shanghai and Nairobi, Creadev invests in companies well positioned to evolve and become world leaders in their respective sectors. Launched in 2002, Creadev has invested more than 1.8 billion euros in companies in stages ranging from venture capital to growth capital through buyout.

Learn more about https://www.creadev.com/.

About Alira Health:

Alira Health is an international consulting firm at the forefront of healthcare transformation. We offer a suite of integrated services designed to help healthcare and life science companies innovate and grow throughout the lifecycle of their solutions.

Alira Health was founded in 1999 and is headquartered in Framingham, MA, USA. The offices are located in San Francisco, California, United States; Paris, France; Barcelona, ​​Spain; Munich, Germany; Milan, Italy; and Basel and Geneva, Switzerland.

Learn more about https://www.alirahealth.com/.

[ad_2]

More Stories
General insurance sector gross premiums up 10.3% in 1H22